Metabolomics in detection of Chemotoxicity
Chemotherapy drugs capable to cause significant, irreversible, life threatening organ damage which is distressing for patients and might affect the optimal delivery of treatment. Various studies have predicted the risk factors for drug induced organ damage because of lack of biomarker to pick-up these changes in early phase causes potential morbidity and mortality. Metabolomics can address relation between gene, drugs environment and thus increase our ability to predict individual variation in drug response phenotypes.
Related Conference of Metabolomics in detection of Chemotoxicity
Metabolomics in detection of Chemotoxicity Conference Speakers
Recommended Sessions
- Analytical Techniques in Metabolomics
- Computational Methodologies
- Mass Spectroscopy (Ms) based Metabolomics
- Metabolic Modelling and Synthetic Biology
- Metabolomic in the field of Paediatric Medicine
- Metabolomics
- Metabolomics Applications
- Metabolomics Approaches
- Metabolomics in detection of Chemotoxicity
- Metabolomics in Discovering Biomarkers
- Metabolomics in Drug Discovery
- Metabolomics in Nutrition Research
- Metabolomics in Pharmaceutics
- Metabolomics in Precision Medicine
- Metabolomics in Systems Biology
- Metabolomics in the field Of Oncology / Cancer Metabolomic
- Metabolomics in various Diseases
- Nmr-based Metabolomics
- Pharmaco-metabolomics
- Plant and Environmental Metabolomics
- Systems Biology
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Imaging and Super-Resolution Techniques - Structural Biology 2026 (Spain)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomolecular Dynamics and Allostery - Structural Biology 2026 (Spain)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Structural Biology and Artificial Intelligence - Structural Biology 2026 (Spain)
- Cryo-Electron Microscopy (Cryo-EM) - Structural Biology 2026 (Spain)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Integrative and Hybrid Structural Biology - Structural Biology 2026 (Spain)
- Membrane Protein Structure and Dynamics - Structural Biology 2026 (Spain)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Nuclear Magnetic Resonance (NMR) Spectroscopy - Structural Biology 2026 (Spain)
- Protein Engineering and Synthetic Biology - Structural Biology 2026 (Spain)
- Protein Structure and Function - Structural Biology 2026 (Spain)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Structural Basis of Genetic and Metabolic Disorders - Structural Biology 2026 (Spain)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Biology in Drug Discovery - Structural Biology 2026 (Spain)
- Structural Genomics and Proteomics - Structural Biology 2026 (Spain)
- Structural Immunology - Structural Biology 2026 (Spain)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Virus Structure and Host Interactions - Structural Biology 2026 (Spain)
- X-ray Crystallography and Diffraction Methods - Structural Biology 2026 (Spain)
